Sign up Canada
Proactive Investors - Run By Investors For Investors
Markets

PRE-MARKET MOVERS: Johnson & Johnson nudges higher after it beats forecasts but UnitedHealth Group shares drop

Also in the frame in nUS pre-market deals is investment banking behemoth Goldman Sachs and Carbonite Inc
1531828252_shutterstock_293225837.jpg
Johnson & Johnson and its results were in focus in pre-market trade

It's earnings season for sure but US shares are poised for a lower open as traders continue to fret about global growth.

Away from the Netflix bloodbath, pharma and consumer goods giant Johnson & Johnson (NYSE:JNJ) shares were up 0.25% to stand at US$125 in pre-market deals as its results beat profit and revenue projections.

The group's pharma business was behind growth in the second quarter while its consumer unit lagged, it revealed.

The firm has also narrowed its full-year forecast.  The medical device segments topped expectations, while and its consumer unit fell short.

Profit came in at US$1.45 per share, while earnings, adjusted for one-time gains and costs, were US$2.10 per share, or 4 cents better than Wall Street had expected.

Elsewhere, in pre-market deals, UnitedHealth Group Inc (NYSE:UNH) saw shares drop 1.94% to US$252 despite the largest US health insurer reporting  a rise of nearly 28% in quarterly profit on Tuesday, driven by growth across its businesses.

Earnings rose to US$2.98 per share (EPS), in the second quarter to June 30 compared to US$2.32 per share, a year earlier.

Also in pre-market, Goldman Sachs Group Inc (NYSE:GS) shares are down 0.28% to US$230.01 before the bell, as it reported EPS (earnings per share) of US$5.98 a share versus an expected EPS of US$4.66 on Wall Street.

Meanwhile, Carbonite Inc (NASDAQ:CARB) shares were flat in pre-market after losing 6% earlier after the cloud-storage firm announced it was offering 4mln of its common shares and it emerged that David Friend,  the company's co-founder, is selling around 520,000 shares, but Carbonite will not see any proceeds from Friend's sale.


No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use